Form 4 for WST West Pharmaceutical Services
Accepted 2026-02-19 00:00:00 ET · period of report 2026-02-17 · accession 0000105770-26-000018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 | 2026-02-17 | WST | Winters Chad | VP, CAO | A - Grant | $0.00 | +149.68 | 1,513 | +11% | $0 | |
| 2026-02-19 | 2026-02-17 | WST | Winters Chad | VP, CAO | F - Tax | $243.19 | -50.58 | 1,462 | -3% | -$12.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-17 | A | A | 149.68 | $0.00 | 1,512.68 | D | — | — | (F1) These shares result from performance stock units (PSUs) which vested at the end of the respective 2023-2025 PSU performance period and were payable on the transaction date shown. |
| 2 | Common | Common Stock | 2026-02-17 | F | D | 50.58 | $243.19 | 1,462.10 | D | — | — |